Integrative Management of Premenstrual Dysphoric Disorder: The Role of Traditional Chinese Medicine
Depression and Anxiety · 2026-01 · 2026 (1)
DOI: 10.1155/da/1262387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Depression and Anxiety, online erschienen am 10.07.2026. Verfasst von Mengbai Xu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China, qdu.edu.cn. Hauptthemen laut MEDLINE: Premenstrual Dysphoric Disorder, Medicine, Chinese Traditional, Drugs, Chinese Herbal, Acupuncture Therapy. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Premenstrual dysphoric disorder (PMDD) is a severe form of premenstrual syndrome (PMS), affecting 3%–8% of women of reproductive age. It is characterized by emotional, behavioral, and physical symptoms during the luteal phase, primarily driven by neuroendocrine sensitivity to hormonal fluctuations and dysregulation of central neurotransmitter systems. Genetic predisposition and environmental stressors contribute to its onset. Although conventional treatments such as selective serotonin reuptake inhibitors (SSRIs) and hormonal therapies offer symptom relief, they are often accompanied by adverse effects and limited long‐term efficacy. Traditional Chinese medicine (TCM) posits that the core pathogenesis of PMDD lies in the dysfunction of liver’s conveyance and dispersion, which may consistent with modern biological research evidence. TCM approaches, represented by Chinese herbal medicine and acupuncture, may alleviate symptoms of PMDD by targeting and modulating its core modern pathogenic mechanisms. With its few side effects and the unique advantage of individualized treatment based on syndrome differentiation, TCM holds the potential to become a mainstream therapeutic option for PMDD. This narrative review synthesizes evidence from clinical trials, animal and pharmacological studies to explore the efficacy and underlying mechanisms of TCM in the treatment of PMDD and compares these approaches with conventional therapies. Nonetheless, the integration of TCM into mainstream practice for PMDD is still hampered by challenges such as insufficient evidence‐based medical data. Research in TCM focusing on biomarker identification, establishment of standardized treatment protocols, and refinement of efficacy evaluation systems is expected to drive its evolution into a mainstream treatment option for PMDD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traditional Chinese Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China, qdu.edu.cn.
- School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China, bucm.edu.cn.
ORCID-Profile: Mengbai Xu, Jiaxu Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, M., & Chen, J. (2026). Integrative Management of Premenstrual Dysphoric Disorder: The Role of Traditional Chinese Medicine. Depression and Anxiety, 2026(1). https://doi.org/10.1155/da/1262387
Vancouver
Xu M, Chen J. Integrative Management of Premenstrual Dysphoric Disorder: The Role of Traditional Chinese Medicine. Depression and Anxiety. 2026;2026(1). doi:10.1155/da/1262387
BibTeX
@article{Xu2026,
author = {Xu, Mengbai and Chen, Jiaxu},
title = {Integrative Management of Premenstrual Dysphoric Disorder: The Role of Traditional Chinese Medicine},
journal = {Depression and Anxiety},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/da/1262387}
}
EUVIMED